ProQR to Present at the LEERINK Partners Global Healthcare Conference
February 07 2017 - 7:00AM
ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to
changing lives through the creation of transformative RNA medicines
for the treatment of severe orphan diseases such as cystic fibrosis
(CF) and Leber's congenital amaurosis Type 10 (LCA10), today
announced that Daniel de Boer, Chief Executive Officer and Smital
Shah, Chief Financial Officer, will take part in an analyst led
fireside chat during the LEERINK Partners Global Healthcare
Conference on Wednesday, February 15, 2017 at 3:00pm ET. The
conference is being held at the Lotte New York Palace in New York,
NY, USA.
The live and archived webcast of the presentation will be
accessible from the ‘Investor Relations’ section of ProQR’s website
(www.proqr.com) under ‘Events and Presentations’. The archived
webcast will be available for 30 days following the presentation
date.
About ProQR
ProQR Therapeutics is dedicated to changing lives through the
creation of transformative RNA medicines for the treatment of
severe orphan diseases such as cystic fibrosis and Leber’s
congenital amaurosis. Based on our unique proprietary RNA repair
platform technologies we are growing our pipeline with patients and
loved ones in mind. *Since 2012*
Contact: Sariette Witte Investor Relations T:
+1 213 261 8891 ir@proqr.com
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Mar 2024 to Apr 2024
ProQR Therapeutics NV (NASDAQ:PRQR)
Historical Stock Chart
From Apr 2023 to Apr 2024